Drug news
FDA approves Kerydin for treatment of Onychomycosis-Anacor Pharma
Anacor Pharmaceuticals, Inc. has announced that the FDA has ,on 7 July 2014,approved the New Drug Application for Kerydin (tavaborole) topical solution, 5%, the first oxaborole antifungal approved for the topical treatment of Onychomycosis of the toenails. Onychomycosis is a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States, according to Podiatry Today.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
3 mins